常规时段
|
|
|
|
|
||||||||||||
|
|
|
|
|
|
|
|
| 价值评估 |
|
盈利(现时/预测)
5.47/16.68
|
|
企业价值
73.27B
|
| 资产负债 |
|
每股账面净值
88.58
|
| 现金流量 |
|
现金流量率
0.06
|
| 损益表 |
|
收益
20.18B
|
|
每股收益
66.45
|
|
同行比较
|
||||||||||||||||||||||||||||||||||||||||||||||||
|
报价延迟最少15分钟:2025/11/15 03:01 EST
同行比较之报价最少15分钟延迟
|
业务概览
|
|||
| Becton Dickinson is the world's largest manufacturer and distributor of medical surgical products, such as needles, syringes, and sharps-disposal units. The company also manufactures prefilled devices, diagnostic instruments, and reagents,as well as flow cytometry and cell-imaging systems. BD Medical is nearly half of the total business, while BD Life Sciences (26% of 2024 revenue) and BD Interventional (25%) account for the remainder. International revenue accounts for 43%of the company's business. |

193.04 
